What is Normal Cholesterol (What Your Doctor Doesn’t Tell You)
Dr. Eric Berg DC
78,471 views • Save 5 min (5 min read) • yesterday
Video Summary
The video discusses the changing definitions of normal cholesterol levels over time and questions the effectiveness of statin drugs in reducing cardiovascular disease deaths. It explains that LDL cholesterol is not cholesterol itself but a lipoprotein carrier, and differentiates between large, buoyant LDL particles and smaller, denser ones, with the latter being more associated with arterial inflammation and plaque buildup. The speaker posits that insulin resistance, driven by chronic consumption of sugars and starches, is the primary cause of increased small, dense LDL particles. The video also touches upon potential conflicts of interest in guideline-setting bodies and the misleading statistics used in drug advertising. It suggests natural remedies and lifestyle changes as alternatives to statins.
Short Highlights
- Cholesterol definitions have changed significantly over decades, leading to more diagnoses of high cholesterol.
- Small, dense LDL particles, linked to insulin resistance, are more problematic than large, buoyant ones.
- Conflicts of interest may exist within organizations setting cholesterol guidelines.
- Natural remedies and lifestyle changes are presented as alternatives to statins.
Key Details
Shifting Definitions of Normal Cholesterol [0:00]
- The definition of normal cholesterol levels has repeatedly changed since 1963, with each change leading to millions more people being diagnosed with high cholesterol.
- Early guidelines in 1963 set the normal range between 150 and 280, while later guidelines in 1988 and 1993 lowered the threshold to 240 and then 200 respectively.
- By 2004, LDL targets dropped to under 70, and currently, they are recommended to be under 55 for high-risk individuals.
"The number that defines normal right now is not the same number that defined it normal 20 years ago, or even 40 years ago, or even 60 years ago."
Statin Drugs and Cardiovascular Deaths [1:30]
- Despite the widespread use of statins, which nearly doubled between 2002 and 2013, cardiovascular disease remains the leading cause of death in America.
- While statins lower LDL cholesterol levels, cardiovascular deaths have not decreased proportionally, raising questions about their overall effectiveness.
- The approval of the first statin drug, lovastatin, in 1987 preceded the guideline changes in 1988, which is noted as an interesting coincidence.
"If lowering cholesterol is the answer, why is cardiovascular disease still the number one cause of death in America for four decades?"
Understanding LDL Cholesterol [3:10]
- LDL (Low-Density Lipoprotein) is not cholesterol itself but a protein carrier that transports cholesterol and other substances to cells.
- Every cell in the body needs cholesterol, including the brain, which is largely composed of fat.
- The standard lipid panel measures the amount of cholesterol carried by LDL trucks but not the number or size of these trucks.
"LDL is not cholesterol. But LDL stands for low-density lipoprotein. It's a protein carrier, but it also carries vitamins."
LDL Particle Size and Risk [4:15]
- There are two main types of LDL particles: large, buoyant LDL, which are less likely to invade arteries, and small, dense LDL, which can trigger inflammation and plaque formation.
- Two individuals with the same LDL number can have different risk factors depending on the proportion of large versus small, dense LDL particles they have.
- Differentiating between these LDL particle types requires an advanced lipid profile test, not the standard cholesterol panel.
"These are like little BB pellets. They do tend to trigger inflammation, and when that inflammation happens, that's where the plaquing starts."
Insulin Resistance as a Driver of High LDL [5:40]
- Insulin resistance, caused by excessive and frequent consumption of glucose from sugars and starches, leads to cells becoming resistant to insulin.
- This resistance causes the body to produce more insulin, and high levels of insulin are identified as a major driver of increased small, dense LDL particles.
- The speaker recommends a fasting insulin test to assess insulin resistance.
"Well, the answer to that is insulin resistance."
Conflicts of Interest in Guidelines [7:00]
- The guidelines for cholesterol management have faced criticism due to potential conflicts of interest among the authors.
- In 2004, eight out of nine authors of the National Cholesterol Education Program update had financial ties to cholesterol-lowering drug manufacturers.
- A 2013 study on ACC and American Heart Association guidelines found that a significant percentage of committee members had ties to pharmaceutical companies.
"Then it came out that eight out of the nine authors had filed to disclose financial associations with the makers of cholesterol-lowering drugs."
Misleading Statistics in Drug Advertising [8:30]
- Drug companies use statistical methods, such as relative risk reduction, to make the benefits of their medications appear more significant than they are.
- For example, a 36% reduction in heart attack risk might mean that for every 100 people taking the drug for years, only one additional person is protected.
- The speaker advocates for more direct and transparent communication of statistics to the public.
"This is exactly what the drug company commercials will tell you in their headlines."
Natural Alternatives and Other Factors [10:00]
- Natural remedies like bergamot extract, berberine, red yeast rice, low-carb diets, and intermittent fasting can help lower LDL cholesterol.
- While these can be effective, the speaker reiterates that insulin resistance is the primary driver of problematic LDL particles.
- Other factors that can drive up LDL include inflammation, thyroid issues, chronic stress, and fatty liver disease.
"What is causing this LDL, especially the small dense lipoproteins to go into your arteries and create inflammation and plaquing and giving you a heart attack."